Hypertension is a risk factor for cardiovascular (CV) diseases, either coronary artery disease (CAD), peripheral artery disease (PAD) or cerebrovascular disease (CVD). The relationships between those different localizations of CV disease and the haemodynamic features of hypertension have been poorly evaluated in the past. In the ATTEST study, a geographically representative panel of 3020 general practitioners recruited 8316 consecutive patients with CV diseases (PAD, CAD or CVD, alone or in association). Blood pressure, which was not an inclusion criterion, was then measured and related to the different forms of CV diseases. Blood pressure classification involved 20% normotensive subjects, 24% subjects with controlled hypertension, 42% subjects with isolated systolic hypertension and 14% subjects with systolic-diastolic hypertension, all hypertensives with or without antihypertensive therapy. From multiple regression analysis, it appeared that subjects with systolic hypertension were characterized by the presence of PAD, with little or no presence of CAD and/or CVD. Subjects with systolic-diastolic hypertension were characterized by the presence of CAD and/or CVD, but without PAD. Although the former was only influenced by age, dyslipidaemia and diabetes mellitus influenced the latter. This study confirms the high prevalence of hypertension (80%) in a large population of patients with CV diseases selected in primary care. Analysis of different features of hypertension revealed that isolated systolic hypertension was the most prevalent form of hypertension in this treated population. Finally, one of the predominant goals of secondary prevention in subjects with PAD should be the treatment of isolated systolic hypertension.
Hypertension is a risk factor for cardiovascular (CV) diseases, either coronary artery disease (CAD), peripheral artery disease (PAD) or cerebrovascular disease (CVD). The relationships between those different localizations of CV disease and the haemodynamic features of hypertension have been poorly evaluated in the past. In the ATTEST study, a geographically representative panel of 3020 general practitioners recruited 8316 consecutive patients with CV diseases (PAD, CAD or CVD, alone or in association). Blood pressure, which was not an inclusion criterion, was then measured and related to the different forms of CV diseases. Blood pressure classification involved 20% normotensive subjects, 24% subjects with controlled hypertension, 42% subjects with isolated systolic hypertension and 14% subjects with systolic-diastolic hypertension, all hypertensives with or without antihypertensive therapy. From multiple regression analysis, it appeared that subjects with systolic hypertension were characterized by the presence of PAD, with little or no presence of CAD and/or CVD. Subjects with systolic-diastolic hypertension were characterized by the presence of CAD and/or CVD, but without PAD. Although the former was only influenced by age, dyslipidaemia and diabetes mellitus influenced the latter. This study confirms the high prevalence of hypertension (80%) in a large population of patients with CV diseases selected in primary care. Analysis of different features of hypertension revealed that isolated systolic hypertension was the most prevalent form of hypertension in this treated population. Finally, one of the predominantIntroduction Cardiovascular disease being the first cause of mortality worldwide, and hypertension being the most prevalent cardiovascular risk factor, 1 it is of paramount importance to study the precise relationships existing between different forms of hypertension and different localizations of atherosclerosis.
During antihypertensive drug therapy in patients with previous cardiovascular (CV) event, the goal of treatment is to avoid the recurrence of CV events, particularly those observed in the cerebral, cardiac or renal circulations as well as in the lower limbs. The results of meta analysis indicate nowadays that the prescriptions of antihypertensive agents might differ according to the dominant site of CV events. 2 For instance, blockers of the renin-angiotensin system might be more efficient in preventing cardiac complications whereas calcium entry blockers could be more efficient in preventing cerebral complications. 3 Whether the haemodynamic features of hypertension, which may either be isolated systolic, isolated diastolic or systolic-diastolic, have a part in the therapeutic indications, has not yet been clearly investigated.
When the clinical aspects of end-organ damage are considered in hypertensive subjects, an increased incidence of systolic hypertension is particularly observed in subjects with cerebrovascular complications and, more recently, in subjects with chronic renal disease. 4 In patients with peripheral artery disease (PAD), systolic-diastolic hypertension is not frequently observed but the repartition of subjects between normotensives and isolated systolic hypertensives has not been extensively investigated. 2 In coronary heart disease, it is classically observed that, following myocardial infarction, the incidence of increased systolic blood pressure (SBP) is markedly reduced. 2, 4 Thus, it is important, in a large population of hypertensive subjects with CV end-organ damage, to evaluate the incidence of normal blood pressure (BP), systolicdiastolic hypertension and isolated systolic hypertension according to the various sites of CV events.
The objectives of the ATTEST study ('prise en charge de l'ArTériopaThie oblitErante des membreS inférieurs chez les paTients en médecine générale') 5 were to compare pharmacological treatment (primary objective) and medical management, including cardiovascular tests and physician's assessment of future cardiovascular and amputation risks (secondary objectives) of patients with established PAD to patients with other vascular site(s) involved in atherothrombosis. The objective of the analysis of the ATTEST study presented in the present paper is to compare the prevalence of the different varieties of hypertension as systolic-diastolic hypertension and isolated systolic hypertension and to determine which category of atherosclerotic CV events may affect the heart, the brain and the lower limbs, respectively with regard to these varieties.
Materials and methods

Population
The design of the ATTEST study has been reported elsewhere. 5 Briefly, this investigation was an observational, cross-sectional, epidemiologic study that took place in France between April and November 2003. Patients were selected by a geographically representative panel of 3020 general practitioners who agreed to participate. Each physician was asked to include the first three patients identified from his or her practice to fulfill the inclusion criteria. These criteria were patients (1) 418 years old, (2) with at least one site of proven atherosclerotic CV disease: PAD of the lower limbs for two patients, and proven coronary artery disease (CAD) or cerebrovascular disease (CVD) for the third patient and who were (3) willing to participate in the study and give consent after receiving written and oral information. A total of 8316 patients were included (all data completed) and analyzed. The protocol was approved by the institutional review committees 'Conseil National de l'Ordre des Médecins', 'Comité Consultatif sur le Traitement de l'Information en Matière de Recherche dans le domaine de la Santé', 'Commission Nationale Informatique et Liberté', Paris, France.
Atherosclerotic diseases were defined using the International Classification of Diseases (10th edition). PAD was defined from typical symptoms and severe (470%) stenosis at arterial duplex or arteriography (99% of patients had arterial duplex examinations), and/or a history of surgical or percutaneous transluminal treatment for lower limb arterial disease (excluding the renal and splanchnic circulation and abdominal aortic aneurysm). CAD was defined as any history of angina pectoris (chest pain precipitated by exertion and relieved by rest or nitrates) confirmed by coronary angiography, myocardial infarction, typical sequelae on electrocardiography, coronary percutaneous transluminal angioplasty, or coronary artery bypass surgery or a combination. CVD was defined by history of ischaemic stroke confirmed by computed tomography or magnetic resonance imaging.
A physician-completed inclusion questionnaire contained the following data: gender, age, weight, height, personal history of diabetes mellitus, dyslipidaemia, or hypertension, current and previous smoking habit, CV tests previously performed, and current use of antiplatelet, antihypertensive, lipidlowering and antidiabetic drugs. These medical data were not obtained from a formal testing protocol, and the ATTEST study was not planned to add any tests to the management of the patients. Rather, physicians were asked to give the most precise information present in their medical files. Diabetes mellitus was diagnosed on the basis of plasma glucose 47.0 mmol l À1 and/or antidiabetic treatment. Dyslipidaemia was defined on the basis of guidelines that prevailed at the time of inclusion and/or presence of hypolipidaemic treatment. 6 
BP classification
Blood pressure was measured after a 5-min rest. Different devices were used according to the device generally used by the practitioner, and the mean of three determinations was considered as systolic (S) and diastolic (D) BP. Pulse pressure was calculated as PP ¼ SBP-DBP. Mean blood pressure was
Based on these measurements and on questionnaires (previous diagnosis of hypertension), the BP classification was composed of four groups (Table 1) Subjects with systolic and systolic-diastolic hypertension were either treated or untreated by antihypertensive drug therapy (see Table 1 ).
Statistical analysis
The total population was divided into three categories of atherosclerotic diseases: patients with isolated PAD (n ¼ 3127), patients with PAD associated with atherosclerotic event in at least one other location, CAD or CVD (n ¼ 3128) and patients with CAD or CVD, or both, but without PAD (n ¼ 2061). Quantitative parameters were described by using means and s.d., and qualitative parameters by number and percent. Qualitative parameter distributions within the three groups were analyzed using the w 2 -test. Analysis of variance was used for quantitative parameter comparisons among the two hypertensive groups; no post hoc test was performed. A Po0.05 was considered significant. All analyses were performed using SAS 9.1 software (SAS Institute, Cary, NC, USA). Table 1 indicates, in the total population, CV risk factors, BP parameters and pharmacological treatment according to the BP classification. From 'normotension' to 'controlled hypertension', 'systolic hypertension' and 'systolic þ diastolic hypertension', there was a positive and significant (Po0.0001) increase of almost all the studied variables. Note that, whatever the antihypertensive agent studied, the proportions of treated subjects with hypertension were relatively low (generally between 30 and 40%) as well in controlled and noncontrolled subjects. The lower proportions were observed for angiotensin II receptor antagonists: between 2 and 23%. Figure 1 illustrates in percent the different sites of CV events as function of the BP classification. In the totality of the population, patients with normal BP represented 44% of subjects, including 20% normotensives and 24% controlled hypertensives; 'systolic hypertension' 42% and 'systolic-diastolic hypertension', 14%: Po0.0001 for intergroup comparisons. From intragroup comparisons, it appears that the PAD groups, that is, with or without associated CAD or CVD, represented 70 to 80% of subjects, the Abbreviations: n, number of subjects; LDL, low-density lipoprotein; ACE, angiotensin-converting enzyme; RA, receptor antagonist. *P-values are adjusted on age and sex.
Results
Arterial disease and hypertension ME Safar et al remaining population (20 to 30%) representing subjects with CAD and/or CVD without PAD. All the intragroup comparisons were statistically significant (Po0.0001). Table 2 shows the multiple regression analysis of isolated systolic and systolic-diastolic hypertension. For isolated systolic hypertension, there were three characteristics: (i) a positive association with SBP contrasting with a negative association with DBP, thus indicating the specific role of PP, (ii) the presence of PAD, in contrast with the negative association of CAD and/or CVD and (iii) the role of age. For systolic-diastolic hypertension, the pattern differed markedly: (i) positive association with SBP and DBP, (ii) presence of CAD and/or CVD, but negative association with isolated PAD, (iii) role of metabolic disorders linked to plasma glucose and lipids.
Discussion
This study was performed in a large population of subjects with at least one site of proven atherosclerotic organ damage, represented by PAD and/or CAD and/or CVD. Approximately half had normal BP and half had hypertension. From the hypertensive subjects, the majority was characterized by isolated systolic, and not systolic-diastolic, hypertension. This haemodynamic pattern was primarily associated with PAD, whether CAD or CVD were present or not. Taken together, these results suggest that isolated systolic hypertension is one of the dominant problems for patients in secondary cardiovascular prevention, namely those with PAD.
On account of the classical difficulties of BP measurements, the present results should be analyzed with caution. Because the population is mainly composed of old people, increased variability of BP is present, making difficult the diagnosis of systolic hypertension. 7 More specifically, the diagnosis of normal BP may be overestimated, because of the relative presence of antihypertensive drug therapy. The most important difficulty of diagnosis is that, in atherosclerotic subjects, noninvasive determination of BP gives usually adequate Arterial disease and hypertension ME Safar et al measurements for SBP, but not for DBP. 8, 9 Comparison between non-invasive and intra-arterial BP measurements have shown that the frequency of increased DBP is often overestimated, 8 and in consequence, that the incidence of isolated systolic hypertension in the elderly is frequently underestimated. 9, 10 In addition, the absence of a single device for BP measurements has probably increased the heterogeneity of BP measurements, leading to increased misclassification in BP groups and then to decreased power of statistical analysis. Finally, it is important to note that the ATTEST study is not an epidemiological survey; as the physicians had to recruit two subjects with PAD and one with CAD/ CVD, the resulting prevalence of isolated systolic hypertension is somewhat biased. A different selection of PAD versus CAD/CVD could have resulted in a lower prevalence of systolic hypertension in the ATTEST study.
An important result of this study was the significant association that we observed between systolic hypertension and the presence of PAD. In most subjects with PAD, ejection fraction and ventricular ejection are preserved, giving no cardiac explanation to the frequency of systolic hypertension in this population. 10, 11 Increased SBP in subjects with PAD is mainly because of increased arterial stiffness and disturbed timing and amplitude of central wave reflections. [12] [13] [14] More specifically, reflection sites are closer from the heart than in normal subjects, because of the importance of structural alterations of the aortic bifurcations, as extensively shown from arteriography. 12 This interpretation is strengthened by the presence of an increased frequency of systolic hypertension around 50 years of age in subjects with traumatic amputation of the lower limbs. 15 In these patients the height of SBP is proportional to the number of lower limb amputations and therefore to the number and diffusion of reflection sites, which all together become closer from the heart. In contrast, in this study, subjects with CAD and/or CVD, but without PAD, had a lower incidence of systolic hypertension, but a relatively high incidence of systolicdiastolic hypertension.
In this study, other explanations may be proposed for the significant association between haemodynamic features of hypertension and sites of CV events. First, in subjects with increased arterial stiffness, increased SBP may be attenuated or even disappear in the presence of reduced ventricular ejection. 2 This haemodynamic pattern is frequently observed in subjects with CAD, particularly following myocardial infarction. Second, drug treatment may interfere with BP level in several subjects of the studied population. Sodium excess and b-blocking agents may increase SBP through increase in arterial stiffness and disturbed wave reflections, whereas nitrates and angiotensin-converting enzyme inhibitors (ACEI) have an opposite effect. 12, [16] [17] [18] Third, stenoses of renal artery are relatively frequent in subjects with PAD and favour the presence of systolic-diastolic hypertension. 19 Finally, clinical studies have shown that increased arterial stiffness and disturbed wave reflections are not only frequent in subjects with PAD but also are significantly associated with reduced walking distance and impaired vasodilating arteriolar properties. [20] [21] [22] Mostly, all these disorders may be attenuated by chronic ACEI treatment. 23, 24 Thus, such results taken together suggest that a more active drug therapy should be quite relevant to consider in subjects with systolic hypertension and target organ damage, particularly those with PAD. Other studies report bad blood pressure control in patients in secondary prevention; after a major cardiovascular event, the EUROASPIRE II 25 survey showed that 'only' half of the population (including normotensives and hypertensives) had normal BP. Similarly, in our study, 45% of the patients had normal BP and 30% of the hypertensives were controlled.
In the PARTNERS program, 26 it has been widely reported that participants with PAD are treated less intensively with antihypertensive and antiplatelet therapy and cholesterol-lowering agents, than those with CAD. This study indicates a quite similar trend (Table 1) . Thus an improvement of PAD management should be nowadays of primary importance for the development of CV prevention in subjects with hypertension, particularly those with isolated systolic hypertension.
What is known about the topic K Hypertension is a risk factor for cardiovascular diseases, either coronary artery disease, peripheral artery disease or cerebrovascular disease. K Patients with peripheral artery disease are treated less intensively with antihypertensive, antiplatelet therapy and cholesterol-lowering agents, than those with coronary artery disease. K The relationships between the different localizations of cardiovascular disease and the haemodynamic varieties of hypertension have been poorly evaluated in the past What this study adds K This study confirms the high prevalence of hypertension (80%) in a large population of patients with cardiovascular diseases selected in primary care. K Analysis of different features of hypertension revealed that isolated systolic hypertension was the most prevalent form of hypertension in this treated population. K Our results suggest that isolated systolic hypertension is one of the dominant problems for patients in secondary cardiovascular prevention, namely those with peripheral artery disease.
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